Yale early stage ovarian cancer detection technology licensed by LabCorp
New Haven, Conn. -- Yale University today announced that it has granted an exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp) for the commercialization of the university's blood testing technology for epithelial ovarian cancer (EOC). ... ...In the United States, EOC is the fourth most common cancer in women, and the leading cause of gynecologic cancer death. E...